Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

AI/ML INNOVATIONS Aktie

 >Aktienkurs 
0.024 EUR    (TradegateBSX)
Ask: 0.027 EUR / 0 Stück
Bid: 0.02 EUR / 0 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
Aktie über LYNX handeln
>Performance
1 Woche: -14,9%
1 Monat: -14,9%
3 Monate: -1,3%
6 Monate: -27,5%
1 Jahr: -44,6%
laufendes Jahr: +8,8%
>AI/ML INNOVATIONS Aktie
Name:  AI/ML INNOVATIONS
Land:  Kanada
Sektor:  Gesundheit
ISIN/ Wkn:  CA00143Y1034 / A2QMBE
Symbol/ Ticker:  42FB (Frankfurt)
Kürzel:  FRA:42FB, ETR:42FB, 42FB:GR
Index:  -
Webseite:  https://www.aiml.health/
Profil:  Ai/Ml Innovations Inc. operates in the transformative field of artificial intelligence and machine learning technologies. The primary function of the company is to develop, implement, and manage AI-based solutions that drive efficiencies and innovati..
>Volltext..
Marktkapitalisierung:  5.53 Mio. EUR
Unternehmenswert:  4.93 Mio. EUR
Umsatz:  0.1 Mio. EUR
EBITDA:  -3.75 Mio. EUR
Nettogewinn:  -4.07 Mio. EUR
Gewinn je Aktie:  -0.02 EUR
Schulden:  0.11 Mio. EUR
Liquide Mittel:  0.69 Mio. EUR
Operativer Cashflow:  -3.45 Mio. EUR
Bargeldquote:  1.21
Umsatzwachstum:  -52.9%
Gewinnwachstum:  -72.82%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  AI/ML INNOVATIONS, AI ML INNOVATIONS
Letzte Datenerhebung:  05.04.26
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 253.99 Mio. St.
Frei handelbar: 43.51%
Leerverk. Aktien: -
Rückkaufquote: -63.15%
Mitarbeiter: -
Umsatz/Mitarb.: -
Analysten:
Analystenrating: No rating
Kursziel: -
Bewertung:
KGV: -
KGV lG: -
KUV: 64.34
KBV: 4.56
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: -1581.01%
Gewinnmarge: -3910.21%
Operative Marge: -3640.31%
Managementeffizenz:
Gesamtkaprendite: -308.12%
Eigenkaprendite: -817.87%
>Peer Group
Gesundheit
 
31.03.26 - 13:06
 AI/ML Innovations Inc.: Neural Cloud Signs Reseller Agreement with European Digital Cardiac Monitoring Platform (Accesswire)
 
Collaboration Expands Reach of MaxYield into Remote Heart Monitoring and Preventive Cardiology Applications TORONTO, ON / ACCESS Newswire / March 31, 2026 / AI/ML Innovations Inc. ("AIML" or the "C......
27.03.26 - 22:06
 AI/ML Innovations Inc. Announces Closing of First Tranche of Private Placement to Raise $950,000 (Accesswire)
 
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, ON / ACCESS Newswire / March 27, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company")......
25.03.26 - 12:06
 AI/ML Innovations Inc.: AIML Subsidiary NeuralCloud Enters Research Services Agreement with Baker Heart and Diabetes Institute to Support AI-Driven ECG Analysis (Accesswire)
 
Agreement expands NeuralCloud's role in cardiovascular research and academic collaborationsMaxYield platform to support heart rate variability analysis in post-exertional malaise research TORONTO, ......
13.03.26 - 00:43
 AI/ML Innovations Inc. Announces Proposed Private Placement of Convertible Debentures (Accesswire)
 
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, ON / ACCESS Newswire / March 12, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company")......
24.02.26 - 13:39
 AI/ML Innovations Inc.: Neural Cloud Enters Distribution Agreement with Intelimed to Expand into Latin America (Accesswire)
 
Intelimed Appointed Exclusive Distributor in Chile and Non-Exclusive Distributor Across Latin America to lead commercialization in the region TORONTO, ON / ACCESS Newswire / February 24, 2026 / AI/......
12.02.26 - 13:06
 AI/ML Innovations Inc.: AIML Subsidiary NeuralCloud Signs Non-Binding Agreement with Movesense to Pilot AI-Powered ECG and Holter Reporting (Accesswire)
 
Collaboration enables deployment of MaxYield and CardioYield into third-party health systems and clinic sitesThis pilot expands the Movesense collaboration to scale low-cost, AI-powered 1-lead ECG ......
10.02.26 - 13:06
 AI/ML Innovations Inc.: Neural Cloud Retains Commission Wolf to Accelerate U.S. Commercial Expansion (Accesswire)
 
Engagement Supports Commercial Readiness Strategy for MaxYield and CardioYield in the United States TORONTO, ON / ACCESS Newswire / February 10, 2026 / AI/ML Innovations Inc. ("AIML" or the "Compan......
28.01.26 - 13:06
 AI/ML Innovations Inc.: AIML Appoints Dr. Paul Dorian as Medical Innovation Architect and Head of the Medical Advisory Board (Accesswire)
 
World Renowned Cardiologist and Research Leader to Guide Clinical Strategy, Product Innovation, and AI-Driven Cardiac Diagnostics TORONTO, ON / ACCESS Newswire / January 28, 2026 / AI/ML Innovation......
20.01.26 - 13:42
 AI/ML Innovations Inc.: AIML Subsidiary NeuralCloud Collaborates with Movesense to Expand Bundled ECG Solutions for Clinical and Wellness Markets (Accesswire)
 
Collaboration enables integrated device-plus-AI offerings supporting scalable ECG analysis, visualization, and report generationCombination of single-lead wearable devices and AI algorithms creatin......
08.01.26 - 13:06
 AI/ML Innovations Inc.: AIML subsidiary NeuralCloud Solutions Inc., Signs Non-Binding Commercial Term Sheet with Lakeshore Cardiology to Deploy CardioYield for AI-Powered Holter Analysis (Accesswire)
 
Agreement positions NeuralCloud's AI-driven cardiac platform for Holter monitoring and ambulatory patient workflow.Partnership introduces CardioYield powered by MaxYield for automated, reliable Hol......
07.01.26 - 13:30
 AI/ML Innovations appoints Erik Suokas as COO (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.01.26 - 13:06
 AI/ML Innovations Inc.: AI/ML Appoints Erik Suokas as Chief Operating Officer to Accelerate Commercial Execution and Operational Scale (Accesswire)
 
Appointment Supports AIML's Commercial Execution and Operational Scale as the Company Advances Its AI-Driven Cardiac PlatformLeadership Addition Aligns Revenue, Delivery, and Product Execution as A......
30.12.25 - 13:42
 AI/ML Innovations, Inc.: AIML Announces the Conclusion of Consulting Agreement and Leadership Transition for President & Chief Commercial Officer (Accesswire)
 
TORONTO, ON / ACCESS Newswire / December 30, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) has announced that its consulting agreement with Campfire Prop......
16.12.25 - 13:42
 AI/ML Innovations, Inc.: Join AIML′s Live Shareholder Update with Chairman & CEO Paul Duffy (Accesswire)
 
A Look Back at Key Milestones and Successes Achieved in 2025What's Ahead: Exciting Plans, Strategic Outlook, and Goals for 2026Advancing the Next Phase of Commercialization TORONTO, ON / ACCESS New......
11.12.25 - 13:42
 AI/ML Innovations, Inc.: AIML Announces Engagement of Guerilla Capital for Communications and Investor Outreach Efforts (Accesswire)
 
TORONTO, ON / ACCESS Newswire / December 11, 2025 / AI/ML Innovations Inc. (CSE:AIML) ("AIML" or the "Company") is pleased to announce the engagement of Guerilla Capital ("Guerilla"), an arm's leng......
09.12.25 - 13:42
 AI/ML Innovations, Inc.: AIML subsidiary NeuralCloud Solutions Signs Commercial Term Sheet with Culminate H Labs to Deploy MaxYield and Insight360 into INTRINSICA′s DNA-Guided Biofeedback Wellness Ecosystem (Accesswire)
 
This strengthens NeuralCloud's expansion into the global wellness and B2B health practitioner delivery model with high-fidelity cardiac signal processing and digital health integration.Partnership ......
02.12.25 - 13:42
 AI/ML Innovations, Inc.: AIML Subsidiary NeuralCloud Enters Pilot with Cornerstone Physiotherapy to Deploy MaxYield and Insight360 for Elite Athlete Cardiac Performance Testing (Accesswire)
 
Early collaboration supports development of Cornerstone's emerging athlete-performance program and extends NeuralCloud's ECG analytics into sports-science and human performance marketsPilot ties Ma......
26.11.25 - 13:42
 AI/ML Innovations, Inc.: AIML Subsidiary NeuralCloud Signs Commercial Term Sheet With Equimetrics To Deploy Maxyield And Cardioyield Across Equine Cardiac Monitoring Platforms (Accesswire)
 
Agreement expands NeuralCloud's AI-enhanced ECG signal-processing technology into veterinary health and elite equine performance marketsCommercial integration expands MaxYield and CardioYield into ......
24.11.25 - 13:42
 AI/ML Innovations, Inc.: AI/ML Subsidiary Neural Cloud Begins Pilot at SickKids to Advance AI-Enabled Pediatric Cardiac Care (Accesswire)
 
Pilot Project to Explore AI-Driven ECG Signal Processing and Predictive Deterioration Models in Pediatric Cardiac Care TORONTO, ON / ACCESS Newswire / November 24, 2025 / NeuralCloud Solutions Inc.......
11.11.25 - 13:42
 AI/ML Innovations, Inc.: AI/ML Innovations Inc. Announces Grant of U.S. Patent Protecting Core ECG Signal-Processing Architecture (Accesswire)
 
Patent validates AIML's novel neural-network approach to denoising and mapping ECG signals, powering MaxYield and CardioYield.Reinforces competitive advantage as the Company advances commercializat......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Das sind halt die Freuden eines Preisministers, wenn ab und zu nicht alles teurer wird. - Dr. Josef Staribacher
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!